Cargando…
Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2(R207X) mouse model
Although a disease-modifying therapy for classic late infantile neuronal ceroid lipofuscinosis (CLN2 disease) exists, poor understanding of cellular pathophysiology has hampered the development of more effective and persistent therapies. Here, we investigated the nature and progression of neurologic...
Autores principales: | Takahashi, Keigo, Eultgen, Elizabeth M., Wang, Sophie H., Rensing, Nicholas R., Nelvagal, Hemanth R., Dearborn, Joshua T., Danos, Olivier, Buss, Nicholas, Sands, Mark S., Wong, Michael, Cooper, Jonathan D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Clinical Investigation
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10266778/ https://www.ncbi.nlm.nih.gov/pubmed/37104037 http://dx.doi.org/10.1172/JCI165908 |
Ejemplares similares
-
Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizures
por: Dearborn, Joshua T., et al.
Publicado: (2022) -
Spinal manifestations of CLN1 disease start during the early postnatal period
por: Nelvagal, H. R., et al.
Publicado: (2020) -
Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep
por: Nelvagal, Hemanth R., et al.
Publicado: (2022) -
Comparative proteomic profiling reveals mechanisms for early spinal cord vulnerability in CLN1 disease
por: Nelvagal, Hemanth R., et al.
Publicado: (2020) -
Glial Dysfunction and Its Contribution to the Pathogenesis of the Neuronal Ceroid Lipofuscinoses
por: Takahashi, Keigo, et al.
Publicado: (2022)